PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Weintraub, Daniel
TI  - MODERATO Study to Assess the Effect of Rasagiline on Patients With Parkinson Disease and Mild Cognitive Impairment
DP  - 2015 Jun 20
TA  - MD Conference Express
PG  - 9--9
VI  - 15
IP  - 9
4099  - http://mdc.sagepub.com/content/15/9/9.short
4100  - http://mdc.sagepub.com/content/15/9/9.full
AB  - Parkinson disease (PD) with mild cognitive impairment (PD-MCI) is relatively common in nondemented PD patients, but currently there is no approved treatment. The phase 4 MODERATO is evaluating the effect of 24 weeks of treatment with rasagiline 1 mg/d as add-on therapy in adults with PD-MCI. The trial, which has enrolled 170 patients, is the largest to date to evaluate a treatment for PC-MCI.